1
0
0
News
Penn's James Wilson takes new role at gene therapy ...
www.bizjournals.com
— Olivier Danos, previously senior vice president for cell and gene therapy at Biogen, to serve as chief scientific officer. The hiring is a ... › news
Biogen enters eye-treatment arena with AGTC deal | Reuters
www.reuters.com
Biogen said on Thursday it had forged a deal with AGTC to develop gene-based therapies for a range of eye diseases, marking the company's entry into...
TxCell Appoints Biogen's Dr. Olivier Danos, Pioneer in Gene Therapy...
www.finanznachrichten.de
SAB now composed of four world-leading immunology experts, including Prof. Zelig Eshhar, who recently received the Novartis Prize for Clinical Immunology...
Netzwerk-Profile
LinkedIn: Olivier. Danos - directeur de recherche - CNRS | LinkedIn
Découvrez le profil de Olivier. Danos sur LinkedIn, la plus grande communauté professionnelle au monde. Olivier. indique 1 poste sur son profil. Consultez le ...
LinkedIn: Olivier. Danos - directeur de recherche - CNRS | LinkedIn
View Olivier. Danos' profile on LinkedIn, the world's largest professional community. Olivier. has 1 job listed on their profile. See the complete profile on LinkedIn ...
LinkedIn: 查看Olivier. Danos的完整檔案 - LinkedIn
快到全球最大的專業人士人脈網查看Olivier. Danos的檔案！Olivier.新增了1 項工作經歷。查看完整檔案，進一步探索Olivier.的人脈和相關職缺。
LinkedIn: Olivier. Danos - LinkedIn
上领英，在全球领先职业社交平台查看Olivier. Danos的职业档案。Olivier.的职业档案列出了1 个职位。查看Olivier.的完整档案，结识职场人脉和查看相似公司的职位。
Interessen
Serum Active Arylsulfatase B and Urinary Glycosaminoglycans.
evidence.nejm.org
— D., John J. Mitchell, M.D., F.R.C.P., Olivier Danos, Ph.D., Jean-Brice Marteau, Ph.D., Stefania Galimberti, Ph.D ... › asset › evidoa
Gene therapy takes further steps into the clinic - The Lancet
www.thelancet.com
von RHB Fishman · — ... reflecting the move “from working hypotheses into clinical studies”, said EWGT president Olivier Danos (Genethon, Evry, France). › fulltext
REGENXBIO: Gene Therapy Pioneer Moving Seeking Alpha
seekingalpha.com
vor 19 Stunden — As for leadership lineup, Chief Scientific Officer Dr. Olivier Danos prior served as SVP Cell and Gene Therapy at Biogen. › article
Business-Profile
patentbuddy: Olivier Danos
ROCHE MOLECULAR SYSTEMS, INC.
Biographie von Olivier Danos - The Official Board
www.theofficialboard.de
Olivier Danos ist derzeit Senior Vice President and Chief Scientific Officer bei RegenxBio. Bei RegenxBio hat Olivier Danos 26 Kollegen einschließlich Ken Mills …
Private Homepages
Firalis Scientific Advisory Board
www.firalis.com
Olivier Danos is a founder associate, member of the Supervisory Board and the Chairman of the Scientific Advisory Board of FIRALIS SA. › about › fi...
Bücher
Bienvenue dans la thérapie génique
von Marie Odile Monchicourt Olivier Danos, Platypuss Press, 2002, Taschenbuch
Gene Therapy Methods - Google Books
books.google.de
This volume in the prestigious Methods in Enzymology series discusses methods currently used in preclinical and clinical gene therapy. Subjects covered in this...
History of AIDS: Emergence and Origin of a Modern Pandemic - Mirko D....
books.google.de
By drawing on the latest discoveries in virology, microbiology, and immunology, Mirko Grmek depicts the AIDS epidemic not as an isolated incident but as part...
Targeting of Drugs: Strategies for Gene Constructs and Delivery -...
books.google.de
Comprising the proceedings of the 10th NATO Advanced Studies Institute forum held in Marathon, Greece in June-July 1999, this volume contains 21 contributions...
Dokumente zum Namen
J: A high throughput method for genome-wide analysis of ...
citeseerx.ist.psu.edu
von J Mantovani · Zitiert von: 10 — author = {Julie Mantovani and Nathalie Holic and Kelly Martinez and Olivier Danos and Javier Perea}, title = {J: A high throughput method for genome-wide ... › viewdoc
CD4+CD25+ regulatory T cells inhibit immune-mediated ...
ashpublications.org
von DA Gross · · Zitiert von: 47 — Olivier Danos,. Olivier Danos. From Généthon/Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) › blood
RNA Interference Shows Critical Requirement for NF-κB p
www.jimmunol.org
von D Laderach · · Zitiert von: 110 — Diego Laderach, Daniel Compagno, Olivier Danos, William Vainchenker and Anne Galy. J Immunol August 15, 2003, 171 (4) ; ... › content
Wissenschaftliche Veröffentlichungen
Comparative proteomics of wild-type and nef-deleted HIV
retrovirology.biomedcentral.com
von C Brégnard · · Zitiert von: 1 — Comparative proteomics of wild-type and nef-deleted HIV-1 particles. Christelle Brégnard,; Olivier Danos &; Stéphane Basmacioqullari. › ...
Veröffentlichungen allgemein
Construction of Retro viral Packaging Cell Lines | SpringerLink
link.springer.com
Editor Affiliations. 1. Chester Beatty Laboratories, Institute of Cancer Research. Authors. Olivier Danos (2). Author Affiliations. 2. Institut Pasteur, Paris, France ...
Oalib search
www.oalib.com
Search Results: of matches for " Olivier Danos " All listed articles are free for downloading (OA Articles) ...
Artikel & Meinungen
INTERVIEW: Biogen's Danos on why now is gene therapy's time
scrip.pharmaintelligence.informa.com
— After a few decades of searching for viable means for delivering gene therapy, Biogen Idec's Olivier Danos said the field finally is at a ... › ...
:: François Hollande (le Young Leader) et ses amis Américains &...
nonmerci.jimdo.com
Olivier Danos Mary Wadsworth Darby David Elias Michel Garcin Catherine Hodeir Mary Jo Jacobi-Jephson Bruno Lafont James M. Landers
Lentiviral vectors can be used for full-length dystrophin gene ...
www.nature.com
von JR Counsell · · Zitiert von: 4 — Jennifer E. Morgan &; Olivier Danos. Show authors. Scientific Reports volume 7, Article number: (2017) Cite this article Accesses. › ... › errata
Sonstiges
Olivier Danos | LinkedIn
www.linkedin.com
View Olivier Danos's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Olivier Danos discover inside ...
Es fehlt: lexington books
Olivier Danos | Professional Profile
www.linkedin.com
View Olivier Danos’ profile on LinkedIn, the world's largest professional community. Olivier has 9 jobs listed on their profile. See the complete profile on ...
US A - Recombinant retroviruses with amphotropic and ecotropic...
patents.google.com
Packaging cell lines useful for the generation of helper-free recombinant retroviruses with amphotropic or ecotropic host ranges, methods of constructing...
UCL Centre for Stem Cells and Regenerative Medicine – Google My Maps
www.google.com
Locations of all laboratories and institutes participating in the UCL Centre for Stem Cells and Regenerative Medicine.
View our website at...
Olivier Danos | BioFuturebiofuture.com › olivier-danos
biofuture.com
Olivier Danos is Senior Vice President and Chief Scientific Officer at REGENXBIO. He is a pioneer in the field of gene therapy, and has dedicated his career ...
Olivier Danos Joins Biogen Idec, Inc. (Massachusetts) As Senior Vice...
www.biospace.com
Biogen Idec today announced that Olivier Danos, Ph.D., has joined the company as senior vice president, Gene Therapy. Dr. Danos reports directly to
citybizlist : Baltimore : REGENXBIO Appoints Olivier Danos, Ph.D., as...
baltimore.citybizlist.com
· Olivier Danos, Ph.D. ROCKVILLE, Md., March 28, (GLOBE NEWSWIRE) -- REGENXBIO Inc. (Nasdaq:RGNX), a leading clinical-stage biotechnology ...
Olivier Danos Insider Trading Overview
www.insidermole.com
Get the latest insider transactions of Olivier Danos. Olivier Danos is a Chief Scientific Officer in REGENXBIO Inc. ($RGNX).
Verwandte Suchanfragen zu Olivier Danos
| Gene Therapy |
Personen Vorname "Olivier" (4516) Name "Danos" (118) |
sortiert nach Relevanz / Datum